. RIPK1 kinase activity induces caspase-8-dependent apoptosis and RIPK3 and mixed lineage kinase like (MLKL)-dependent necroptosis [8] [9] [10] [11] [12] [13] . In addition, RIPK1 inhibits apoptosis and necroptosis through kinase-independent functions, which are important for late embryonic development and the prevention of inflammation in epithelial barriers [14] [15] [16] [17] [18] . The mechanism by which RIPK1 counteracts RIPK3-MLKL-mediated necroptosis has remained unknown. Here we show that RIPK1 prevents skin inflammation by inhibiting activation of RIPK3-MLKL-dependent necroptosis mediated by Z-DNA binding protein 1 (ZBP1, also known as DAI or DLM1). ZBP1 deficiency inhibited keratinocyte necroptosis and skin inflammation in mice with epidermisspecific RIPK1 knockout. Moreover, mutation of the conserved RIP homotypic interaction motif (RHIM) of endogenous mouse RIPK1 (RIPK1 mRHIM ) caused perinatal lethality that was prevented by RIPK3, MLKL or ZBP1 deficiency. Furthermore, mice expressing only RIPK1 mRHIM in keratinocytes developed skin inflammation that was abrogated by MLKL or ZBP1 deficiency. Mechanistically, ZBP1 interacted strongly with phosphorylated RIPK3 in cells expressing RIPK1 mRHIM , suggesting that the RIPK1 RHIM prevents ZBP1 from binding and activating RIPK3. Collectively, these results show that RIPK1 prevents perinatal death as well as skin inflammation in adult mice by inhibiting ZBP1-induced necroptosis. Furthermore, these findings identify ZBP1 as a critical mediator of inflammation beyond its previously known role in antiviral defence and suggest that ZBP1 might be implicated in the pathogenesis of necroptosisassociated inflammatory diseases.
) caused perinatal lethality that was prevented by RIPK3, MLKL or ZBP1 deficiency. Furthermore, mice expressing only RIPK1 mRHIM in keratinocytes developed skin inflammation that was abrogated by MLKL or ZBP1 deficiency. Mechanistically, ZBP1 interacted strongly with phosphorylated RIPK3 in cells expressing RIPK1 mRHIM , suggesting that the RIPK1 RHIM prevents ZBP1 from binding and activating RIPK3. Collectively, these results show that RIPK1 prevents perinatal death as well as skin inflammation in adult mice by inhibiting ZBP1-induced necroptosis. Furthermore, these findings identify ZBP1 as a critical mediator of inflammation beyond its previously known role in antiviral defence and suggest that ZBP1 might be implicated in the pathogenesis of necroptosisassociated inflammatory diseases.
Mice with epidermis-specific RIPK1 deficiency (Ripk1 fl/fl K14-cre Tg/WT , hereafter referred to as RIPK1 E-KO ) develop skin inflammation owing to RIPK3-MLKL-dependent keratinocyte necroptosis 14 . We hypothesized that other RHIM-containing proteins may induce RIPK3-MLKL-mediated necroptosis in RIPK1-deficient keratinocytes. In addition to RIPK1 and RIPK3, the only other proteins containing RHIM in humans and mice are TRIF and ZBP1 (refs 3, 6, 19, 20) . We showed previously that TRIF deficiency very mildly ameliorates but does not prevent skin inflammation in RIPK1 E-KO mice 14 , suggesting that TRIF is not essential for RIPK3 activation and necroptosis in RIPK1-deficient epidermal keratinocytes. ZBP1 is a RHIM-containing protein previously identified as a cytoplasmic DNA sensor capable of inducing type I interferon expression and NF-κ B activation [19] [20] [21] [22] [23] . More recently, ZBP1 was shown to induce necroptosis by activating RIPK3 independently of RIPK1 in response to cytomegalovirus infection 24 .
We therefore hypothesized that ZBP1 might be implicated in triggering RIPK3 activation and necroptosis in epidermal keratinocytes of RIPK1 E-KO mice. Immunoblot analysis of epidermal extracts showed that ZBP1 was expressed at low levels in wild-type mice but its expression was strongly increased in the epidermis of RIPK1 E-KO mice at the age of four weeks (Fig. 1a) , supporting the idea that ZBP1 could be involved in triggering keratinocyte necroptosis in this model. To address the potential role of ZBP1 in triggering keratinocyte necroptosis and skin inflammation in RIPK1 E-KO mice, we crossed them with Zbp1 −/− mice 25 . RIPK1 E-KO Zbp1 −/− mice did not show macroscopic signs of skin disease at the age of four weeks, in contrast to RIPK1 E-KO animals that displayed inflammatory skin lesions at this age (Extended Data Fig. 1a ). Histological analysis confirmed that 4-5-week-old RIPK1 E-KO Zbp1 −/− animals did not develop skin E-KO mice at postnatal day 3 (P3) and P28. Lanes represent samples from individual mice. For gel source data, see Supplementary  Fig. 1 . b, Skin sections from 4-5-week-old mice were stained with H&E or immunostained with the indicated antibodies. Representative images shown (RIPK1 E-KO n = 9 for H&E and n ≥ 6 for immunostainings; RIPK1 E-KO Zbp1 −/− n = 10 for H&E and n ≥ 3 for immunostainings). Scale bars, 50 μ m. c, Microscopic quantification of epidermal thickness and inflamed skin area in 4-5-week-old mice with the indicated genotypes. d, qRT-PCR analysis of the mRNA expression of the indicated cytokines and chemokines in RNA isolated from total skin from 4-5-week-old mice with the indicated genotypes. * P ≤ 0.05; * * P ≤ 0.01; * * * P ≤ 0.005. letter reSeArCH
lesions, as shown by normal epidermal thickness and typical expression of epidermal differentiation markers including keratins 14, 10 and 6 (Fig. 1b, c) . In addition, the skin of RIPK1 E-KO Zbp1 −/− mice did not show increased infiltration of F4/80 + myeloid cells and upregulation of inflammatory cytokines and chemokines (Fig. 1b, d ). ZBP1 deficiency also reduced the number of keratinocytes stained with terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) in the epidermis of RIPK1 E-KO mice (Extended data Fig. 1e , f), suggesting that it prevented keratinocyte necroptosis. RIPK1 E-KO Zbp1 −/− mice remained healthy until the age of 18-20 weeks, but subsequently progressively developed inflammatory skin lesions; however, these remained milder and focal compared to the severe inflammation affecting the entire skin observed in 4-5 week-old RIPK1 E-KO mice (Extended Data Fig. 1b-d) . Therefore, ZBP1 deficiency strongly inhibited, but did not completely prevent, skin inflammation in RIPK1 E-KO mice, in contrast to RIPK3 or MLKL deficiency that fully abrogated lesion development in these animals 14 . These results suggest that ZBP1 plays a critical role in the induction of RIPK3-MLKL-dependent keratinocyte necroptosis in RIPK1 E-KO mice but, in its absence, alternative mechanisms can activate RIPK3 to trigger necroptosis. Although keratinocyte-specific TRIF deficiency did not considerably inhibit skin inflammation in RIPK1 E-KO mice 14 , it is possible that TRIF might contribute to skin lesion development in the absence of ZBP1 in adult RIPK1 E-KO Zbp1 −/− animals. To address whether ZBP1 is generally required for keratinocyte necroptosis we assessed the role of ZBP1 in mice with epidermis-specific FADD deficiency (FADD E-KO ), which develop skin inflammation owing to RIPK3-mediated keratinocyte necroptosis 26 . FADD E-KO Zbp1 −/− mice developed skin inflammation similarly to FADD E-KO mice, showing that ZBP1 deficiency did not inhibit RIPK3-dependent skin inflammation in this model (Extended Data Fig. 2) . Thus, ZBP1 induces keratinocyte necroptosis in the absence of RIPK1 but it is not required for keratinocyte necroptosis and skin inflammation caused by epidermal FADD deficiency.
We reasoned that RIPK1 might prevent ZBP1-mediated RIPK3 activation by interacting with these two proteins through its RHIM domain. To specifically address the role of the RHIM domain of RIPK1 in vivo, we generated knock-in mice expressing a mutated RIPK1 protein in which the QIG conserved amino acids of the RHIM domain at position 529-531 were substituted with alanines (RIPK1(QIG529→ 531AAA), hereafter referred to as RIPK1 mRHIM ) using CRISPR/Cas9-mediated gene targeting in mouse zygotes (Extended Data Fig. 3a) . Genotyping of progeny obtained from intercrossing heterozygous Ripk1 mRHIM/WT mice from two independently generated knock-in lines failed to identify any homozygous Ripk1 mRHIM/mRHIM mice at weaning age (Fig. 2a) . Examination of pups obtained from timed matings revealed that Ripk1 mRHIM/mRHIM mice were alive at E18.5 but died perinatally, similarly to Ripk1 −/− mice [15] [16] [17] 27 . and Ripk1 −/− pups (Fig. 2b, c) . Analysis of intestinal tissues revealed scarce presence of CC3 + apoptotic cells in Ripk1 mRHIM/mRHIM pups compared to the increased number of CC3 + cells found in the intestine of Ripk1 −/− mice (Extended Data Fig. 3b, c) . Earlier studies showed that the epidermal hyperplasia observed in Ripk1 −/− pups depends on RIPK3-MLKL-mediated necroptosis 17 , whereas the intestinal epithelial cell apoptosis is driven by FADD/caspase-8-dependent apoptosis 14, 15, 17, 18 . Inhibition of both necroptosis and apoptosis was required to overcome the perinatal lethality of Ripk1 −/− mice [15] [16] [17] letter reSeArCH Fig. 2d ) and ZBP1 deficiency also prevented perinatal lethality of these mice, with Ripk1 mRHIM/mRHIM Zbp1 −/− mice surviving at least up to the age of 5 months without showing apparent abnormalities (Extended Data Table 1 , Extended Data Fig. 4a, b) . TRIF knockout did not rescue the Ripk1 mRHIM/mRHIM mice (Extended Data Table 1 ). Therefore, in contrast to RIPK1 deficiency that causes perinatal lethality owing to both caspase-8-mediated apoptosis and RIPK3-MLKL-mediated necroptosis [15] [16] [17] , mutation of RIPK1 RHIM caused perinatal death exclusively owing to ZBP1-RIPK3-MLKL-dependent necroptosis.
To confirm that the RIPK1(QIG→ AAA) mutation disrupted the interaction of RIPK1 with RIPK3, we stimulated primary MEFs from Ripk1 mRHIM/mRHIM mice with TNF in the presence of cycloheximide and Z-VAD-FMK (TCZ treatment) for different periods of time to induce formation of the necrosome. Immunoblot analysis of RIPK1 immunoprecipitates revealed that RIPK3 strongly interacted with RIPK1 in TCZ-treated wild-type, but not in Ripk1 mRHIM/mRHIM , primary MEFs (Fig. 3a) . Consistently, primary Ripk1 mRHIM/mRHIM MEFs showed reduced cell death in response to TCZ treatment and fetal liver macrophages (FLMs) from Ripk1 mRHIM/mRHIM pups were resistant to necroptosis induced by stimulation with TNF and Z-VAD-FMK (TZ treatment) (Fig. 3b, c) . Notably, we routinely obtained reduced numbers of FLMs from Ripk1 mRHIM/mRHIM compared to wild-type embryos, and the expression levels of ZBP1 were reduced in the Ripk1 mRHIM/mRHIM cells (Fig. 3d) , suggesting that Ripk1 mRHIM/mRHIM FLMs expressing high levels of ZBP1 may be counter-selected in these cultures. Therefore, disruption of the RHIM-dependent interaction of RIPK1 with RIPK3 protected primary FLMs and MEFs from TNF-induced necroptosis. TNF-induced NF-κ B activation was not impaired in Ripk1
MEFs or FLMs (Fig. 3e, f) , showing that RHIM-dependent RIPK1 interactions are not required for TNFR1-induced proinflammatory signalling.
To address whether RIPK1 prevents keratinocyte necroptosis and skin inflammation in a RHIM-dependent manner, we crossed Ripk1 mRHIM/E-KO mice developed macroscopically visible signs of skin lesions starting at about 3-4 weeks after birth, which progressively developed to inflammatory skin disease by the age of 9-11 weeks (Fig. 4a-c, Extended Data Fig. 5a-d) . Histological analysis showed that the skin lesions in RIPK1 mRHIM/E-KO mice resembled those seen in RIPK1 E-KO mice, characterized by epidermal hyperplasia and impaired differentiation, increased numbers of dying keratinocytes as well as increased F4/80 + myeloid cell infiltration and upregulation of inflammatory cytokine and chemokine expression (Fig. 4a-c, Extended Data Fig. 5c-d) . As in RIPK1 E-KO mice, homozygous, but not heterozygous, MLKL deficiency prevented skin lesion development in RIPK1
mRHIM/E-KO mice at least up to the age of 22 weeks, showing that the inflammatory skin disease is triggered by MLKL-mediated keratinocyte necroptosis (Fig. 4a-c , Extended Data Fig. 5a-d) . RIPK1
mRHIM/E-KO mice showed increased expression of ZBP1 in the skin, similarly to RIPK1 E-KO mice (Fig. 4d, e) . ZBP1 was not expressed in primary keratinocytes from wild-type, RIPK1 E-KO or RIPK1
mRHIM/E-KO mice (Extended Data Fig. 6a ), suggesting that its upregulation in the epidermis could be triggered by signals related to the in vivo tissue context. Indeed, the increased expression of Ifnb1 in the skin of RIPK1
mRHIM/E-KO mice could be responsible for the upregulation of ZBP1 expression (Fig. 4e) , as stimulation with IFNβ induced robust ZBP1 expression in cultured primary keratinocytes from wildtype, RIPK1
E-KO and RIPK1 mRHIM/E-KO mice (Extended Data Fig. 6b ). In line with our findings in RIPK1 E-KO animals, ZBP1 deficiency prevented the development of skin lesions in RIPK1
mRHIM/E-KO mice at least up to the age of 21 weeks (Fig. 4a-c, Extended Data Fig. 5a, c, d ). These results showed that RHIM-dependent RIPK1 function in epidermal keratinocytes is critical to prevent ZBP1-mediated activation of RIPK3-MLKL-driven necroptosis and skin inflammation.
We postulated that RIPK1 may bind ZBP1 and prevent its interaction with RIPK3. As ZBP1 is not expressed in MEFs, we transduced primary wild-type or Ripk1 mRHIM/mRHIM MEFs with a lentiviral vector expressing Flag-tagged murine ZBP1. Immunoblotting of anti-Flag immunoprecipitates with anti-RIPK3 antibodies showed that ZBP1 interacted weakly with RIPK3 in wild-type MEFs, but this interaction was strongly enhanced in Ripk1 mRHIM/mRHIM MEFs (Fig. 4f) . A slower migrating RIPK3 species was detected in the anti-Flag immunoprecipitate suggesting that ZBP1 could preferentially associate with phosphorylated RIPK3. Indeed, immunoblotting with monoclonal antibodies specifically recognizing RIPK3 phosphorylated at serine 232 (ref. 28) revealed that the slower migrating band corresponded to phosphorylated RIPK3 (Fig. 4f) . Caspase-8 or MLKL were not detected in the anti-Flag immunoprecipitate, suggesting that these proteins do not interact with ZBP1 under these conditions (Fig. 4f) . Immunoblotting with anti-RIPK1 antibodies failed to detect RIPK1 in the anti-Flag immunoprecipitate (Fig. 4f) . Moreover, reciprocal immunoprecipitation using anti-RIPK1 antibodies and immunoblotting with anti-Flag or anti-ZBP1 antibodies also failed to detect an interaction between RIPK1 and ZBP1 (Fig. 4g) . Therefore, in contrast to RIPK3, RIPK1 did not interact with ZBP1 in primary MEFs. It is not clear why our results differ from previous studies showing that ZBP1 interacted with RIPK1 in 293T cells 19, 20 , but this could be related to the absence of RIPK3 expression in 293T cells 9 . Taken together, our results showed that, in the absence of the RIPK1 RHIM domain, ZBP1 strongly interacted with RIPK3 and induced its autophosphorylation, which triggered downstream activation of MLKL and necroptosis. The inhibitory role of the RIPK1 RHIM domain is letter reSeArCH particularly important for the maintenance of skin homeostasis during late embryonic life and in adult mice. As the lack of RIPK1, or mutation of its RHIM, specifically in the epidermis triggers keratinocytes necroptosis and inflammation starting a few weeks after birth, whereas ubiquitous RIPK1 deficiency or RHIM mutation triggers necroptosis of dermal cells and results in perinatal death, it is likely that the skin hyperplasia during late embryonic life and the associated perinatal lethality are caused by necroptosis of non-epithelial, perhaps stromal or myeloid, cells. Although the precise mechanism of the RIPK1 RHIM-dependent inhibition of ZBP1-mediated RIPK3 activation remains unknown at present, it is possible that RIPK1 associ ates with RIPK3 to prevent its interaction with ZBP1. At this stage, it is also unclear whether the nucleic acid sensing properties of ZBP1 are involved in activating RIPK3-dependent necroptosis in the absence of the RIPK1 RHIM domain. Taken together, our results revealed an important role of the RIPK1 RHIM domain in counteracting ZBP1-mediated activation of RIPK3-MLKL-dependent necroptosis, which is critical for preventing lethality during late embryogenesis and skin inflammation in adult mice. These findings identify ZBP1 as a potent inducer of inflammation beyond its role in anti-viral defence 24, 29 and suggest that it could be implicated in inflammatory diseases. Future studies will be required to elucidate the mechanism of ZBP1 activation and how RIPK1 inhibits it, but also its potential implication in the pathogenesis of human diseases.
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Relative expression
Relative expression −/− (ref. 25) mice were described previously. Mice were maintained at the SPF animal facilities of the Institute for Genetics and the CECAD Research Center of the University of Cologne, under a 12 h light cycle, and given a regular chow diet (Harlan, diet number 2918 or Prolab Isopro RMH3000 5P76) ad libitum. All animal procedures were conducted in accordance with European, national and institutional guidelines and protocols were approved by local government authorities (Landesamt für Natur, Umwelt und Verbraucherschutz Nordrhein-Westfalen, Germany). Animals requiring medical attention were provided with appropriate care and were killed when they developed macroscopically visible skin lesions to minimize suffering. No other exclusion criteria existed. Mice of the indicated genotype were assigned at random to groups. Mouse studies as well as immunohistochemical assessment of pathology were performed in a blinded fashion. In order to co-immunoprecipitate ZBP1 interacting proteins, ZBP1 cDNA was generated from IFNβ (97265, Biomol) stimulated wild-type primary MEFs using Superscript III first-strand kit (18080-051, Invitrogen) and the sequence confirmed DNA was cloned into lentiviral pBOB-Flag vector (provided by J. Han, Xiamen University). Primary wild-type and Ripk1 mRHIM/mRHIM MEFs were transduced with recombinant lentiviruses. Four days after infection, the cell lysates were prepared in immunoprecipitation buffer (20 mM HEPES-KOH (pH 7.6), 150 mM NaCl, 2 mM EDTA, 1% Triton X-100, 10% Glycerol). Flag tag immunoprecipitation was performed by anti-DYKDDDDK antibody magnetic beads (017-25151, Wako) and RIPK1 was precipitated by antibody against RIPK1 (610459, BD) which was BS3-crosslinked to Dynabeads (10004D, Life Technologies). Cell death assay. Primary MEFs and fetal-liver-derived macrophages were seeded in 96 well plates (1 × 10 4 cells per well for MEF and 2 × 10 4 cells per well for FLM) one day before TNF treatment. On the experiment day, indicated amounts of recombinant murine TNF (VIB Protein Service Facility, Ghent), cycloheximide (A0879, Applichem), Z-VAD-FMK (N-1560, Bachem) and Nec-1 (BML-AP309, Enzo) were added to cells. Eighteen hours after incubation, cell viability was determined by neutral red assay as described 32 . Keratinocytes isolation, culture and stimulation. Keratinocytes from newborn pups were isolated using dispase II (D4693, Sigma). The skin was incubated in dispase II overnight at 4 °C. After incubation, epidermis was separated and incubated with TrypLE (12605-010, Gibco) for 20 min and flushed with medium, centrifuged and cultured in low Ca 2+ DMEM/Ham's F12 medium (F 9092-0.46, Biochrom) with 10% chelax treated FCS and supplements. For immunoblot analyses, 4 × 10 5 cells were seeded in collagen coated 6 well plates and three hours before stimulation the medium was replaced by fresh medium without EGF. Keratinocytes were stimulated by 20 ng ml −1 TNF or 1,000 U ml −1 IFNβ for eighteen hours. Quantitative RT-PCR. Total RNA from skin tissue was extracted with Trizol Reagent (Life Technologies) and RNeasy Columns (Qiagen) and cDNA was prepared with Superscript III cDNA-synthesis Kit (Life Technologies). qRT-PCR of Il1b, Il6, Il33, Tnf, Cxcl3, Ccl3, Ccl5 and Ccl4 genes was performed with TaqMan probes (Life Technologies). The expression of Zbp1, Ifnb1 and Ppia in Fig. 4e were analysed using SYBR Green master mix (4367659, Thermo) with the following primer sets: Zbp1 forward: 5'-GCTATGACGGACAGACGTGG-3', Zbp1 reverse: 5'-TGTTGACCGGATTGTGCTGA-3', Ifnb1 forward: 5'-AGCT CCAAGAAAGGACGAACA-3', Ifnb1 reverse: 5'-GCCCTGTAGGTGA GGTTGATCT-3', Ppia forward: 5'-ATGGTCAACCCCACCGTGT-3', Ppia reverse: 5'-TTTCTGCTGTCTTTGGAACTTTGTC-3'. HPRT and Tbp for TaqMan and PPIa for SYBR Green were used as reference genes. Data were analysed according to the Δ C t method. Statistical analysis. Data shown in column graphs represent mean ± s.e.m. To determine group size necessary for adequate statistical power, power analysis was performed using preliminary data sets. For statistical analysis of data from qRT-PCR, quantification of epidermal thickness and inflamed area, when data did not fulfil the criteria for Gaussian distribution, nonparametric Mann-Whitney test was performed. Unpaired Student's t-test was performed for the quantification of TUNEL and CC3 staining. Paired Student's t-test was performed for statistical analysis of results obtained from cell viability assays. * P ≤ 0.05; * * P ≤ 0.01; * * * P ≤ 0.005. Statistical analysis was performed using Graphpad Prism and Microsoft Excel. Data availability statement. The authors declare that the data supporting the findings of this study are available within the paper. Source data for all figures are provided with the paper. The Ripk1 mRHIM mice are available from the corresponding author upon request. 
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